{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:57:30Z","timestamp":1767992250374,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"7-8","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1023\/b:ddas.0000037803.32013.aa","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T21:06:10Z","timestamp":1092431170000},"page":"1149-1155","source":"Crossref","is-referenced-by-count":50,"title":["Tumor M2-Pyruvate Kinase, a New Metabolic Marker for Pancreatic Cancer"],"prefix":"10.1007","volume":"49","author":[{"given":"Maurizio","family":"Ventrucci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Cipolla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Racchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Casadei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Simoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucio","family":"Gullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"494213_CR1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00006676-199207000-00012","volume":"7","author":"A Malesci","year":"1992","unstructured":"Malesci A, Montorsi M, Mariani A, Santambrogio R, Bonato C, Bissi O, Tacconi M, Wizemann G, Spina G: Clinical utility of the serum CA 19-9 test for diagnosing pancreatic carcinoma in symptomatic patients: a prospective study. Pancreas7:497\u2013502, 1992","journal-title":"Pancreas"},{"key":"494213_CR2","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/00006676-199411000-00007","volume":"9","author":"L Gullo","year":"1994","unstructured":"Gullo L: CA 19-9: the Italian experience. Pancreas9:717\u2013719, 1994","journal-title":"Pancreas"},{"key":"494213_CR3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0016-5085(87)90840-7","volume":"92","author":"A Malesci","year":"1987","unstructured":"Malesci A, Tommasini MA, Bonato C, Bocchia P, Bersani M, Zerbi A, Beretta E, Di Carlo V: Determination of CA 19-9antigen in serum and pancreatic juice for differential diagnosis of pancreatic adenocarcinoma from chronic pancreatitis. Gastroenterology92:60\u201367, 1987","journal-title":"Gastroenterology"},{"key":"494213_CR4","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1002\/1097-0142(19880515)61:10<2100::AID-CNCR2820611028>3.0.CO;2-Z","volume":"61","author":"M Paganuzzi","year":"1988","unstructured":"Paganuzzi M, Onetto M, Marroni P, Barone D, Conio M, Aste H, Pugliese V: CA 19.9 and CA 50 in benign and malignant pancreatic and biliary diseases. Cancer61:2100\u20132108, 1988","journal-title":"Cancer"},{"key":"494213_CR5","first-page":"91","volume":"3","author":"E Eigenbrodt","year":"1992","unstructured":"Eigenbrodt E, Reinacher M, Scheefers-Borchel U, Scheefers H, Friis R: Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells. Crit Rev Oncog3:91\u2013115, 1992","journal-title":"Crit Rev Oncog"},{"key":"494213_CR6","first-page":"3267","volume":"18","author":"E Eigenbrodt","year":"1998","unstructured":"Eigenbrodt E, Kallinowski F, Ott M, Mazurek S, Vaupel P:Pyruvate kinase and interaction of amino acid and carbohydrate metabolism in solid tumors. Anticancer Res18:3267\u20133274, 1998","journal-title":"Anticancer Res"},{"key":"494213_CR7","unstructured":"Eigenbrodt E, Basenau D, Holthusen S, Mazurek S, Fischer G: Quantification of tumor type M2 pyruvate kinase (Tu M2-PK) in human carcinomas. Anticancer Res 3153\u20133156, 1997"},{"key":"494213_CR8","first-page":"2599","volume":"19","author":"GM Oremek","year":"1999","unstructured":"Oremek GM, Teigelkamp S, Kramer W, Eigenbrodt E, Usadel KH: The pyruvate kinase isoenzyme tumor M2 (Tu M2-PK) as a tumor marker for renal carcinoma.Anticancer Res19:2599\u20132601, 1999","journal-title":"Anticancer Res"},{"key":"494213_CR9","first-page":"5077","volume":"20","author":"D Luftner","year":"2000","unstructured":"Luftner D, Mesterharm J, Akrivakis C, Geppert R, Petrides PE, Wernecke KD, Possinger K: Tumor type M2 pyruvate kinase expression in advanced breast cancer.Anticancer Res20:5077\u20135082, 2000","journal-title":"Anticancer Res"},{"key":"494213_CR10","first-page":"531","volume":"24","author":"J Schneider","year":"2000","unstructured":"Schneider J, Morr H, Velcovsky HG, Weisse G, Eigenbrodt E: Quantitative detection of tumor M2-pyruvate kinase in plasma of patients with lung cancer in comparison to other lung diseases. Cancer Detect Prev24:531\u2013535, 2000","journal-title":"Cancer Detect Prev"},{"key":"494213_CR11","first-page":"4965","volume":"20","author":"PD Hardt","year":"2000","unstructured":"Hardt PD, Ngoumou BK, Rupp J, Schnell-Kretschmer H, Kloer HU: Tumor M2-pyruvate kinase: a promising tumor marker in the diagnosis of gastro-intestinal cancer. Anticancer Res20:4965\u20134968, 2000","journal-title":"Anticancer Res"},{"key":"494213_CR12","first-page":"4961","volume":"20","author":"G Schulze","year":"2000","unstructured":"Schulze G: The tumor marker tumor M2-PK: An application in the diagnosis of gastrointestinal cancer. Anticancer Res20:4961\u20134964,2000","journal-title":"Anticancer Res"},{"key":"494213_CR13","first-page":"849","volume":"19","author":"H Cerwenka","year":"1999","unstructured":"Cerwenka H, Aigner R, Bacher H, Werkgartner G, el-Shabrawi A, Quehenberger F, Mischinger HJ: TUM2-PK (pyruvate kinase type tumor M2), CA19-9 and CEA in patients with benign, malignant and metastasizing pancreatic lesions. Anticancer Res19:849\u2013851, 1999","journal-title":"Anticancer Res"},{"key":"494213_CR14","first-page":"3031","volume":"17","author":"GM Oremek","year":"1997","unstructured":"Oremek GM, Eigenbrodt E, Radle J, Zeuzem S, Seiffert UB: Value of the serum levels of the tumor marker TUM2-PK in pancreatic cancer. Anticancer Res17:3031\u20133034, 1997","journal-title":"Anticancer Res"},{"key":"494213_CR15","volume-title":"Illustrated Guide to the TNM\/pTNM Classification of Malignant Tumours","author":"UICC TNM Atlas","year":"1989","unstructured":"UICC TNM Atlas: Illustrated Guide to the TNM\/pTNM Classification of Malignant Tumours, 3rd ed.Berlin, Eidelberg, New York, Springer-Verlag,1989","edition":"3rd ed."},{"key":"494213_CR16","first-page":"2753","volume":"19","author":"F Hugo","year":"1999","unstructured":"Hugo F, Fischer G, Eigenbrodt E: Quantitative detection of tumor M2-PK in serum and plasma.Anticancer Res19:2753\u20132757, 1999","journal-title":"Anticancer Res"},{"key":"494213_CR17","unstructured":"National Cancer Institute: Annual Report to the Nation on the Status of Cancer, 1973-1998. The Surveillance, Epidemiology, and End Results (SEER). NCI, Bethesda, MD."},{"key":"494213_CR18","first-page":"966","volume-title":"The Pancreas","author":"JM Rhodes","year":"1998","unstructured":"Rhodes JM, Yannakou Y, Ching CK: Pancreatic tumor markers. InThe Pancreas HJ Beger (ed). Oxford, Blackwell Science, 1998, pp 966\u2013981"},{"key":"494213_CR19","first-page":"2583","volume":"19","author":"HW Wechsel","year":"1999","unstructured":"Wechsel HW, Petri E, Bichler KH, Feil G: Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK). Anticancer Res19:2583\u20132590, 1999","journal-title":"Anticancer Res"},{"key":"494213_CR20","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1182\/blood.V95.3.1086.003k09_1086_1092","volume":"95","author":"R Oehler","year":"2000","unstructured":"Oehler R, Weingartmann G, Manhart N, Salzer U, Meissner M, Schlegel W, Spittler A, Bergmann M, Kandioler D, Oismuller C, Struse HM, Roth E: Polytrauma induces increased expression of pyruvate kinase in neutrophils. Blood 95:1086\u20131092, 2000","journal-title":"Blood"},{"key":"494213_CR21","first-page":"2969","volume":"23","author":"R Pezzilli","year":"2003","unstructured":"Pezzilli R, Migliori M, Morselli-Labate AM, Campana D, Ventrucci M, Tomassetti P, Corinaldesi R: Diagnostic value of tumor M2-pyruvate kinase in neuroendocrine tumors. A comparative study with chromogranin A. Anticancer Res23:2969\u20132972, 2003","journal-title":"Anticancer Res"},{"key":"494213_CR22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev.nu.09.070189.002305","volume":"9","author":"SA Goldstein","year":"1989","unstructured":"Goldstein SA, Elwyn DH: The effects of injury and sepsis on fuel utilization.Annu Rev Nutr9:445\u2013473, 1989","journal-title":"Annu Rev Nutr"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:DDAS.0000037803.32013.aa.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/B:DDAS.0000037803.32013.aa\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:DDAS.0000037803.32013.aa.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T03:33:34Z","timestamp":1753760014000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/B:DDAS.0000037803.32013.aa"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":22,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["494213"],"URL":"https:\/\/doi.org\/10.1023\/b:ddas.0000037803.32013.aa","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}